Gencay Hatiboglu

2.3k total citations
65 papers, 1.1k citations indexed

About

Gencay Hatiboglu is a scholar working on Pulmonary and Respiratory Medicine, Urology and Molecular Biology. According to data from OpenAlex, Gencay Hatiboglu has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pulmonary and Respiratory Medicine, 20 papers in Urology and 16 papers in Molecular Biology. Recurrent topics in Gencay Hatiboglu's work include Prostate Cancer Diagnosis and Treatment (33 papers), Renal cell carcinoma treatment (19 papers) and Urinary Bladder and Prostate Research (16 papers). Gencay Hatiboglu is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (33 papers), Renal cell carcinoma treatment (19 papers) and Urinary Bladder and Prostate Research (16 papers). Gencay Hatiboglu collaborates with scholars based in Germany, United States and Canada. Gencay Hatiboglu's co-authors include Markus Hohenfellner, Boris Hadaschik, Sascha Pahernik, Jessica Herbst, Sergio P. Acebrón, Stefan Koch, Christof Niehrs, Michael Pinkawa, Jean‐Paul Vallée and Doğu Teber and has published in prestigious journals such as Cell, Clinical Infectious Diseases and The Journal of Urology.

In The Last Decade

Gencay Hatiboglu

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gencay Hatiboglu Germany 19 697 267 221 185 163 65 1.1k
G. Pasticier France 20 1.0k 1.5× 160 0.6× 423 1.9× 130 0.7× 314 1.9× 58 1.5k
Deliu Victor Matei Italy 17 721 1.0× 91 0.3× 279 1.3× 111 0.6× 222 1.4× 42 1.0k
Hiromichi Ishiyama Japan 21 881 1.3× 137 0.5× 396 1.8× 306 1.7× 64 0.4× 103 1.3k
Göran Ahlgren Sweden 18 943 1.4× 174 0.7× 194 0.9× 37 0.2× 199 1.2× 45 1.2k
Fabio Cury Canada 19 647 0.9× 88 0.3× 287 1.3× 368 2.0× 48 0.3× 97 1.1k
Duke Bahn United States 14 1.2k 1.7× 63 0.2× 347 1.6× 124 0.7× 479 2.9× 27 1.4k
R. Harzmann Germany 19 1.1k 1.5× 161 0.6× 450 2.0× 63 0.3× 411 2.5× 94 1.6k
Eric C. Bélanger Canada 18 400 0.6× 196 0.7× 277 1.3× 44 0.2× 96 0.6× 60 779
Roman Ganzer Germany 22 1.3k 1.9× 70 0.3× 510 2.3× 131 0.7× 491 3.0× 94 1.8k
Mohamed Ismail United Kingdom 12 339 0.5× 161 0.6× 111 0.5× 32 0.2× 74 0.5× 50 591

Countries citing papers authored by Gencay Hatiboglu

Since Specialization
Citations

This map shows the geographic impact of Gencay Hatiboglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gencay Hatiboglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gencay Hatiboglu more than expected).

Fields of papers citing papers by Gencay Hatiboglu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gencay Hatiboglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gencay Hatiboglu. The network helps show where Gencay Hatiboglu may publish in the future.

Co-authorship network of co-authors of Gencay Hatiboglu

This figure shows the co-authorship network connecting the top 25 collaborators of Gencay Hatiboglu. A scholar is included among the top collaborators of Gencay Hatiboglu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gencay Hatiboglu. Gencay Hatiboglu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Homberg, Roland, Andreas J. Gross, Thomas Herrmann, et al.. (2024). Bildgebung bei Nephroureterolithiasis. PubMed. 63(3). 295–302.
2.
Yılmaz, Mehmet, et al.. (2024). Salvage irreversible electroporation for locally recurrent prostate cancer after definitive radiotherapy: a systematic review. Prostate Cancer and Prostatic Diseases. 28(3). 707–717. 1 indexed citations
3.
Stenzel, Philipp, Mario Schindeldecker, Larissa Seidmann, et al.. (2023). CD15 Is a Risk Predictor and a Novel Target in Clear Cell Renal Cell Carcinoma. Pathobiology. 91(3). 219–229. 3 indexed citations
4.
Grieshaber, Philippe, et al.. (2022). Cavoatrial hypernephroma resection on cardiopulmonary bypass: Mild/normo-versus moderate hypothermia. Perfusion. 38(8). 1644–1651. 1 indexed citations
5.
6.
Nyarangi‐Dix, Joanne, et al.. (2021). Evolution of Salvage Radical Prostatectomy from Open to Robotic and Further to Retzius Sparing Surgery. Journal of Clinical Medicine. 11(1). 202–202. 7 indexed citations
7.
Görtz, Magdalena, Jan Philipp Radtke, Gencay Hatiboglu, et al.. (2020). The value of PSA density in PI-RADS 3 lesions on multiparametric MRI - a strategy to avoid unnecessary prostate biopsies. European Urology Open Science. 19. e1721–e1721. 1 indexed citations
8.
9.
10.
11.
Macher‐Goeppinger, Stephan, Martina Keith, Gencay Hatiboglu, et al.. (2017). Expression and Functional Characterization of the BNIP3 Protein in Renal Cell Carcinomas. Translational Oncology. 10(6). 869–875. 18 indexed citations
12.
Habl, Gregor, Matthias Uhl, Sonja Katayama, et al.. (2016). Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study—The IPI Trial. International Journal of Radiation Oncology*Biology*Physics. 95(1). 435–443. 49 indexed citations
13.
Du, Yuejun, Carsten Grüllich, Boris Hadaschik, et al.. (2016). Local Recurrence After Curative Surgical Treatment of Renal Cell Cancer: A Study of 91 Patients. Clinical Genitourinary Cancer. 14(4). e379–e385. 12 indexed citations
14.
Hatiboglu, Gencay, Markus Hohenfellner, Boris Hadaschik, et al.. (2016). Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma. Langenbeck s Archives of Surgery. 402(4). 637–644. 21 indexed citations
15.
Roth, Wilfried, Holger Sültmann, Carsten Grüllich, et al.. (2015). Intratumorale Heterogenität des Nierenzellkarzinoms: Molekulare Grundlagen und translationale Implikationen. 54(6). 800–803. 2 indexed citations
16.
17.
Hatiboglu, Gencay, Jesco Pfitzenmaier, Sascha Pahernik, et al.. (2011). UP-02.205 Hydro-Dissection Technique for Fast and Safe Transperineal Spacer Injection. Urology. 78(3). S332–S333. 2 indexed citations
18.
Hatiboglu, Gencay, Ionel Valentin Popeneciu, M. Kurosch, et al.. (2011). Prognostic variables for shockwave lithotripsy (SWL) treatment success: no impact of body mass index (BMI) using a third generation lithotripter. British Journal of Urology. 108(7). 1192–1197. 18 indexed citations
19.
Huber, Johannes, Sascha Pahernik, Peter Hallscheidt, et al.. (2010). Risk factors and clinical management of haemorrhage after open nephron‐sparing surgery. British Journal of Urology. 106(10). 1488–1493. 9 indexed citations
20.
Nyarangi‐Dix, Joanne, D. Schultz‐Lampel, Johannes Huber, et al.. (2010). Konservative Therapie der postoperativen Harninkontinenz des Mannes. Der Urologe. 49(4). 498–503. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Pasticier Breakdown of academic impact, for papers by Deliu Victor Matei Breakdown of academic impact, for papers by Hiromichi Ishiyama Breakdown of academic impact, for papers by Göran Ahlgren Breakdown of academic impact, for papers by Fabio Cury Breakdown of academic impact, for papers by Duke Bahn Breakdown of academic impact, for papers by R. Harzmann Breakdown of academic impact, for papers by Eric C. Bélanger Breakdown of academic impact, for papers by Roman Ganzer Breakdown of academic impact, for papers by Mohamed Ismail
Rankless by CCL
2026